FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

703593009: Serrapeptase (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3008868016 Serrapeptase en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3009464015 Serrapeptase (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3010159010 Serratiopeptidase en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1807901000195118 serrapeptasi it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
42851000188112 Serrapeptase fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Serrapeptase Is a Peptide hydrolase true Inferred relationship Some
Serrapeptase This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Peptide hydrolase (disposition) true Inferred relationship Some
Serrapeptase Is a Hydrolase false Inferred relationship Some
Serrapeptase Is a Protein true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Diclofenac and paracetamol and serrapeptase only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Serrapeptase Inferred relationship Some 3
Product containing diclofenac and paracetamol and serrapeptase in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Serrapeptase Inferred relationship Some 3
Product containing diclofenac and paracetamol and serrapeptase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Serrapeptase Inferred relationship Some 3
Diclofenac and paracetamol and serrapeptase only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Serrapeptase Inferred relationship Some 3
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Serrapeptase Inferred relationship Some 3
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Serrapeptase Inferred relationship Some 3
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Serrapeptase Inferred relationship Some 3
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Serrapeptase Inferred relationship Some 3

This concept is not in any reference sets

Back to Start